학술논문

Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: Results from the randomized phase III IMpower010 trial
Document Type
Article
Source
In: Journal for ImmunoTherapy of Cancer. (Journal for ImmunoTherapy of Cancer, 30 October 2023, 11(10))
Subject
Language
English
ISSN
20511426